Intellectual Property and Public Health: An Overview of the Debate with a Focus on U.S. Policy
Author:
- Carsten FinkCFCarsten Fink
Preprint
- 1 January 2008
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
Over the past fifteen years, the United States and other developed countries have employed trade agreements to substantially strengthen the protection of intellKeywords
All Related Versions
This publication has 17 references indexed in Scilit:
- At what price?Nature, 2007
- Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public goodGlobalization and Health, 2006
- A Patent Policy Proposal for Global DiseasesInnovations: Technology, Governance, Globalization, 2006
- Intellectual Property Provisions of bilateral and Regional Trade Agreements in light of US Federal Law2006
- Resource Book on TRIPS and Development2005
- The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public HealthAmerican Journal of International Law, 2005
- Financing Pharmaceutical Innovation: How Much Should Poor Countries Contribute?The World Bank Economic Review, 2005
- Why Are We Worried About Income? Nearly Everything that Matters is ConvergingWorld Development, 2005
- Pharmaceuticals and the Developing WorldJournal of Economic Perspectives, 2002
- Economic Welfare and the Allocation of Resources for Invention1962